Clarity Pharmaceuticals Ltd. (CU6) Income Statement
133 Followers
Clarity Pharmaceuticals Ltd. Income Statement
Last quarter (Q4 2022), Clarity Pharmaceuticals Ltd.'s total revenue was $―. In Q4, Clarity Pharmaceuticals Ltd.'s net income was $―. See Clarity Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22
Total Revenue
$ ―
Cost of Revenue
$ ―
Gross Profit
$ ―
Operating Expense
$ 30.29M
Operating Income
$ -30.29M
Net Non Operating Interest Income Expense
$ 95.09K
Other Income Expense
$ 6.46M
Pretax Income
$ -23.74M
Tax Provision
$ 17.63K
Earnings From Equity Interest Net Of Tax
$ ―
Net Income Common Stockholders
$ -23.75M
Basic EPS
$ -0.10
Diluted EPS
$ -0.10
Basic Average Shares
$ 247.70M
Diluted Average Shares
$ 247.70M
Dividend Per Share
$ ―
Total Operating Income As Reported
$ ―
Reported Normalized Basic E P S
$ ―
Reported Normalized Diluted E P S
$ ―
Rent Expense Supplemental
$ ―
Total Expenses
$ ―
Net Income From Continuing And Discontinued Operation
$ -23.75M
Normalized Income
$ -23.75M
Interest Expense
$ ―
EBIT
$ -30.29M
EBITDA
$ -30.24M
Currency in USD
Clarity Pharmaceuticals Ltd. Earnings and Revenue History